top of page
News, Events and Updates
Search
Anavex Confirms Data for Phase 2a Alzheimer's Trial for ANAVEX 2-73
Nov 11, 2015
New Exploratory Alzheimer's Drug ANAVEX 2-73 Changes in Electrophysiological Markers in Alzheimer's
Nov 11, 2015
Anavex Announces Positive Primary and Secondary Endpoints were Achieved in a Phase 2a Clinical Trial
Nov 9, 2015
Anavex Announces CTAD 2015 Abstract
Nov 5, 2015
Anavex Commences Trading on NASDAQ Today — To Ring Friday's Closing Bell
Oct 27, 2015
Anavex Announces Uplisting to NASDAQ
Oct 25, 2015
Anavex to Present at 4th Annual OktoberINVESTfest Conference
Oct 11, 2015
Anavex to Present Interim Phase 2a Clinical Trial Data of ANAVEX 2-73 at Late-Breaking Oral Session
Oct 6, 2015
Anavex Prepares for Uplisting to NASDAQ, Announces Reverse Stock Split
Oct 5, 2015
Anavex Completes Patient Enrollment for Phase 2a Alzheimer's Trial Ahead of Schedule
Sep 27, 2015
Anavex to Present at 2015 Ladenburg Thalmann Healthcare Conference
Sep 22, 2015
33
34
35
36
37
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
